These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25377470)

  • 1. Serine deprivation enhances antineoplastic activity of biguanides.
    Gravel SP; Hulea L; Toban N; Birman E; Blouin MJ; Zakikhani M; Zhao Y; Topisirovic I; St-Pierre J; Pollak M
    Cancer Res; 2014 Dec; 74(24):7521-33. PubMed ID: 25377470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
    Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
    Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Repurposing of Biguanides in Cancer.
    Zhao H; Swanson KD; Zheng B
    Trends Cancer; 2021 Aug; 7(8):714-730. PubMed ID: 33865798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
    Janzer A; German NJ; Gonzalez-Herrera KN; Asara JM; Haigis MC; Struhl K
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10574-9. PubMed ID: 25002509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.
    Segal ED; Yasmeen A; Beauchamp MC; Rosenblatt J; Pollak M; Gotlieb WH
    Biochem Biophys Res Commun; 2011 Nov; 414(4):694-9. PubMed ID: 21986525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria.
    Bridges HR; Jones AJ; Pollak MN; Hirst J
    Biochem J; 2014 Sep; 462(3):475-87. PubMed ID: 25017630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biguanide MC001, a Dual Inhibitor of OXPHOS and Glycolysis, Shows Enhanced Antitumor Activity Without Increasing Lactate Production.
    Fu J; Liu S; Hu M; Liao X; Wang X; Xu Z; Li Q; Quan J
    ChemMedChem; 2022 Mar; 17(6):e202100674. PubMed ID: 34984842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs.
    Hsu CC; Wu LC; Hsia CY; Yin PH; Chi CW; Yeh TS; Lee HC
    Oncol Rep; 2015 Sep; 34(3):1620-8. PubMed ID: 26133123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart.
    Heinz S; Freyberger A; Lawrenz B; Schladt L; Schmuck G; Ellinger-Ziegelbauer H
    Arch Toxicol; 2019 Sep; 93(9):2603-2615. PubMed ID: 31324951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K; Kritz H; Regal H; Foltin E
    Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
    Lea MA; Kim H; desBORDES C
    Anticancer Res; 2018 Sep; 38(9):5003-5011. PubMed ID: 30194144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
    Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Animal experimental studies on the mode of action of biguanides. 1. Studies on non hypoglycemically acting biguanide].
    Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
    Arzneimittelforschung; 1972 Sep; 22(9):1540-52. PubMed ID: 4678618
    [No Abstract]   [Full Text] [Related]  

  • 14. [The place of biguanides in the treatment of diabetes].
    Dérot M; Rathery H; Rathery M
    Therapeutique; 1970 Feb; 46(2):167-9. PubMed ID: 5446243
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of biguanides by human organic cation transporter OCT2.
    Sogame Y; Kitamura A; Yabuki M; Komuro S; Takano M
    Biomed Pharmacother; 2013 Jun; 67(5):425-30. PubMed ID: 23582785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents.
    Sweeney D; Raymer ML; Lockwood TD
    Biochem Pharmacol; 2003 Aug; 66(4):663-77. PubMed ID: 12906931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides.
    Birsoy K; Possemato R; Lorbeer FK; Bayraktar EC; Thiru P; Yucel B; Wang T; Chen WW; Clish CB; Sabatini DM
    Nature; 2014 Apr; 508(7494):108-12. PubMed ID: 24670634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of weight reduction by phenformin.
    Stowers JM; Bewsher PD
    Postgrad Med J; 1969 May; 45():12. PubMed ID: 5364309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.